Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Apple Tree Partners
AddedFeb 15, 2024
UpdatedJun 28, 2026
Apple Tree Partners

Apple Tree Partners

Operating

Apple Tree Partners: Investing in healthcare and manufacturing traffic management systems.

Location
New York City, NY, US
Founded
1999
Firm
Compare
Portfolio
Fundraising
Employees
Website

Apple Tree Partners is a life sciences venture capital firm focusing on transformative biotechnology companies. They invest across various stages, from pre-IP ideas to spinouts from existing pipelines, primarily in pharmaceuticals, biotech, medtech, and healthcare services. ATP provides flexible capital and strategic support, typically investing from seed stage through IPO and beyond.

Notable portfolio companies include Stoke Therapeutics, Braeburn, and Galvanize Therapeutics. ATP's investment philosophy centers on building sustainable, research-driven enterprises by offering not just funding but also operational resources and strategic insights. The firm's approach involves creating science-based companies and supporting them throughout their growth journey.

Apple Tree Partners - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments28
Current Portfolio Count18
Total Portfolio Exits0

Top Investment Stages

Series A14 (53.8%)
Seed5 (19.2%)
Series B4 (15.4%)
Series Unknown2 (7.7%)
Debt Financing1 (3.8%)

Stage Mix

Series A 54%Seed 19%Series B 15%Series Unknown 8%Debt Financing 4%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Deep Apple Therapeutics logo

Deep Apple Therapeutics

Ascidian Therapeutics logo

Ascidian Therapeutics

Aulos Bioscience logo

Aulos Bioscience

Initial Therapeutics logo

Initial Therapeutics

Aethon Therapeutics logo

Aethon Therapeutics

Galvanize Therapeutics logo

Galvanize Therapeutics

Marengo Therapeutics logo

Marengo Therapeutics

Intergalactic Therapeutics logo

Intergalactic Therapeutics

Replicate Bioscience logo

Replicate Bioscience

Nereid Therapeutics logo

Nereid Therapeutics

Nine Square Therapeutics logo

Nine Square Therapeutics

Limelight Bio logo

Limelight Bio

Stoke Therapeutics logo

Stoke Therapeutics

Braeburn logo

Braeburn

Elstar Therapeutics logo

Elstar Therapeutics

Rox Medical logo

Rox Medical

VytronUS logo

VytronUS

QualDerm Partners logo

QualDerm Partners

Cure Forward logo

Cure Forward

Apple Tree Partners - Similar Investment Firms

ATP logo

ATP

atpfund.com

Olive Tree Capital logo

Olive Tree Capital

AirTree Ventures logo

AirTree Ventures

Atherton Venture Partners logo

Atherton Venture Partners

ThornTree Capital Partners logo

ThornTree Capital Partners

thorntreecap.com

Red Tree Venture Capital. logo

Red Tree Venture Capital.

CAP logo

CAP

ATW Partners logo

ATW Partners

atwpartners.com

Almond Tree Capital Fund logo

Almond Tree Capital Fund

almondtree.vc

Apricot Capital logo

Apricot Capital

apricotcapital.com

PlumTree Partners logo

PlumTree Partners

Pear Tree Partners logo

Pear Tree Partners

peartreefunds.com

Atlas Venture logo

Atlas Venture

atlasventure.com

Figtree Partners logo

Figtree Partners

Alta Partners logo

Alta Partners

altapartners.com

Apple Tree Partners - Classification

Also Known As
  • Apple Tree Partners, LLC
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 5 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end